Business Context and Reporting Period
Company: Microbot Medical Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 21, 2026
Reporting Period: Single event date (July 21, 2026)
Business Context: The filing serves as a Regulation FD disclosure regarding the participation of the Company's CEO, Harel Gadot, at the Society of Robotic Surgery (SRS) annual meeting.
Key Financial Metrics
This Form 8-K is a current report regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material changes to financial performance or operational status are reported in this filing. The document solely announces a scheduled executive presentation at an industry conference.
Guidance, Outlook, and Management Commentary
- Event: CEO Harel Gadot will present at the Society of Robotic Surgery (SRS) annual meeting in Fort Lauderdale, FL, from July 23-26, 2026.
- Topic: The presentation will cover an overview of the endovascular robotic market and discuss emerging technologies in peripheral vascular, neurovascular, and cardiovascular spaces.
- Access: The panel is scheduled for livestreaming at 10:25 am ET on July 23, 2026.
- Legal Status: The information is furnished under Item 7.01 and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the livestream link and timing for the SRS 2026 presentation (July 23, 10:25 am ET).
- Review the full text of the press release furnished as Exhibit 99.1 for additional details on the market overview.
- Confirm that no other material events were disclosed in this specific filing beyond the conference participation.